Join the presentation and live chat. youtu.be/VXdQSCwF9Go
Today is "Giving Tuesday." Please support our online community and cutting edge prostate cancer research with a generous donation to patient-focused nonprofit Malecare at malecare.org/donate
Prostate Cancer MRI's and Focal Therapy and the side effects patients want to avoid. Caroline Moore is the first woman in the UK to become a Professor of Urology. She is passionate about improving the diagnostic and treatment pathway for men with prostate cancer, using the latest in imaging technology, decision support, and outcomes measurement. She has a particular interest in the use of MRI in the diagnosis and active surveillance of prostate cancer and had led international consensus and group work in this area, including the START1 consensus on reporting studies of MRI-guided biopsy, the PRECISE consensus on reporting MRI in men on active surveillance for prostate cancer and the PRECISION study demonstrating the superiority of an MRI-targeted prostate cancer diagnosis pathway. She also studies the impact of prostate cancer diagnosis and treatment on patient-reported outcome measures.
What is this miracle treatment of which the New York Times speaks today? Clue: it starts with LU
initial treatment Locally advanced combo therapy results compared
Vegetables did not help early PCa surveillance 
Using AI to understand what is the best treatment for each patient
Another short article on benefits of local therapy for advanced PCa
